Cargando…

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen

The rising incidence rate of the cancer in the prostate gland has increased the demand for improved diagnostic, imaging, and therapeutic approaches. Prostate-specific membrane antigen (PSMA), with folate hydrolase and carboxypeptidase and, internalization activities, is highly expressed in the epith...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimadamore, Alessia, Cheng, Monica, Santoni, Matteo, Lopez-Beltran, Antonio, Battelli, Nicola, Massari, Francesco, Galosi, Andrea B., Scarpelli, Marina, Montironi, Rodolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308151/ https://www.ncbi.nlm.nih.gov/pubmed/30622933 http://dx.doi.org/10.3389/fonc.2018.00653

Ejemplares similares

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Microbiome and Cancers, With Focus on Genitourinary Tumors
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Treating Prostate Cancer by Antibody–Drug Conjugates
por: Rosellini, Matteo, et al.
Publicado: (2021)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
por: Cimadamore, Alessia, et al.
Publicado: (2017)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States
por: Santoni, Matteo, et al.
Publicado: (2021)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
por: Mollica, Veronica, et al.
Publicado: (2019)

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Is There a Role for Immunotherapy in Prostate Cancer?
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
por: Aurilio, Gaetano, et al.
Publicado: (2020)

The Identification of Immunological Biomarkers in Kidney Cancers
por: Lopez-Beltran, Antonio, et al.
Publicado: (2018)

Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
por: Mollica, Veronica, et al.
Publicado: (2021)

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
por: Gasparrini, Silvia, et al.
Publicado: (2019)

Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
por: Mollica, Veronica, et al.
Publicado: (2019)

Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments
por: Santoni, Matteo, et al.
Publicado: (2021)

Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
por: Mollica, Veronica, et al.
Publicado: (2021)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

Exploring the Spectrum of Kidney Ciliopathies
por: Santoni, Matteo, et al.
Publicado: (2020)

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
por: Montironi, Rodolfo, et al.
Publicado: (2014)

The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications
por: Aurilio, Gaetano, et al.
Publicado: (2019)

PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?
por: Marchetti, Andrea, et al.
Publicado: (2022)

Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_poh16j78mvr7jqphk3t4meqd2r